VITACILINA FIRST AID ANTIBIOTIC- bacitracin zinc, neomycin sulfate, polymyxin b sulfate ointment 
Taisho Pharmaceutical California Inc.

----------

Vitacilina First Aid Antibiotic

Drug Facts

Active ingredient (in each gram)

Bacitracin Zinc 400 units

Neomycin sulfate 3.5 mg

Polymyxin B sulfate 5,000 units

Purpose

First aid antibiotic

Use

First aid to help prevent infection in minor cuts, scrapes, and burns

Warnings

For external use only.

Do not use

  • if you are allergic to any of the ingredients
  • in the eyes
  • over large areas of the body

Ask a doctor before use if you have

  • deep or puncture wounds 
  • animal bites 
  • serious burns

Stop use and ask a doctor if

  • you need to use longer than 1 week 
  • condition persists to gets worse
  • rash or other allergic reaction develops

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center 

Directions

Other information

Inactive ingredient

petrolatum

Package Labeling 28g

Outer Package

Add image transcription here...

Inner Package

Add image transcription here...

Package Labeling 14g

Outer Package2Inner Package2

VITACILINA FIRST AID ANTIBIOTIC 
bacitracin zinc, neomycin sulfate, polymyxin b sulfate ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81929-003
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BACITRACIN ZINC (UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I) BACITRACIN400 U  in 1 g
NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297) NEOMYCIN3.5 mg  in 1 g
POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K) POLYMYXIN B5000 U  in 1 g
Inactive Ingredients
Ingredient NameStrength
PETROLATUM (UNII: 4T6H12BN9U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:81929-003-011 in 1 CARTON07/01/2022
128 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:81929-003-021 in 1 CARTON07/01/2022
214 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00407/01/2022
Labeler - Taisho Pharmaceutical California Inc. (603827635)

Revised: 11/2023
Document Id: 09ce4763-a8f8-7cff-e063-6294a90a851c
Set id: 93fb9e05-f78c-4d37-b6f1-926cbcb2e7a7
Version: 2
Effective Time: 20231110
 
Taisho Pharmaceutical California Inc.